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The authors regret that an error has appeared in the above article.
The terms ‘exon’ and ‘intron’ have been interchanged in the
chapter LUNG CANCER: POTENTIAL CLINICAL APPLICATIONS OF
GENOMIC SEQUENCING on page 605.
The sentence ‘Whole genome sequencing includes both intron
(coding regions of the DNA) and exons (non-coding regions of the
DNA).’ should correctly read: ‘Whole genome sequencing includes
both exons (coding regions of the DNA) and introns (non-coding
regions of the DNA).’
†DOI of the original article: 10.1093/ejcts/ezu048.
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